Replies to post #160290 on Just Politics

[DrContango]

The guidelines for use of baby aspirin were updated a year ago March.

https://www.jwatch.org/fw115167/2019/03/18/new-guidelines-back-aspirin-primary-cardiovascular

MEDICAL NEWS | PHYSICIAN'S FIRST WATCHCARDIOLOGY
March 18, 2019

New Guidelines Back off Aspirin for Primary Cardiovascular Prevention

By Kelly Young

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

New guidelines say that daily, low-dose aspirin should be used infrequently to prevent primary cardiovascular disease. The American College of Cardiology and the American Heart Association conclude that aspirin should be reserved for people with the highest cardiovascular risk and the lowest risk for bleeding.

The guideline categorically recommends against aspirin use in those over age 70 and in those at high risk for bleeding, such as patients with chronic renal disease or thrombocytopenia. The guidelines were published in JACC and Circulation and presented at ACC's annual meeting.

Among the groups' other recommendations:

For patients with type 2 diabetes and other cardiovascular risk factors, metformin is the first-line treatment. GLP-1R agonists and SGLT-2 inhibitors may now be considered to help reduce CVD risk.

Adults should aim to get at least 150 minutes of moderate or 75 minutes of vigorous physical activity a week, which is consistent with prior guidance.

Statins are recommended with lifestyle changes for patients with elevated LDL levels (at or above 190 mg/dL), type 2 diabetes, or other cardiovascular risk factors.

https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2019/03/07/16/00/2019-acc-aha-guideline-on-primary-prevention-gl-prevention

[DragonBear]

Is aspirin a wonder drug?

And I could post the many wonder drug attributes of Omega-3 found in fish oil. Ranging from dramatically lowering triglycerides, to having mild anti-angiogenic effects, and normalizing lactic acid in the blood - the last two helpful for cancer patients. Also like aspirin it inhibits clotting. Easy to bruise.

One even has the recent journey of Amarin Corporation. You've probably seen their commercials for Vascepa. A form of the EPA Omega-3. Cashing in on its effect for lowering triglycerides. They even ran a successful clinical trial, obtaining FDA approval for the indication. At least ARMN was cashing in until a few days ago, when their patent was successfully challenged by some generics. The stock took a -70% dive. Of course there's no such thing as a fish oil patent. Which can work just as well. Also there's no known fish oil dose that causes organ damage.